Real-time stock price, financial statements, consensus target price, insider trading, and technical analysis for Lunit Inc. (328130:KRX), powered by AI.
Lunit Inc. is currently trading at ₩32,650. View real-time AI analysis on Alpha Lenz.
View the latest insider trading data for Lunit Inc. on Alpha Lenz.
Lunit Inc.'s P/E ratio is -11.4.
“Lunit Inc. trades at a P/E of -11.4 (undervalued) with modest ROE of -41.2%. 3Y revenue CAGR of 101.3% highlights clear growth momentum.”
Ask for details →Lunit Inc. is a pioneering entity in the field of medical artificial intelligence. The company specializes in developing advanced AI-powered diagnostic solutions aimed at enhancing the accuracy and efficiency of medical imaging processes. Lunit Inc.’s core products focus on areas such as radiology and oncology, providing tools that assist healthcare professionals in detecting diseases like cancer more accurately and at earlier stages. These innovations are pivotal in sectors such as hospitals, diagnostic centers, and research institutions, significantly impacting the overall healthcare ecosystem by improving patient outcomes and streamlining clinical workflows. Lunit Inc. continually collaborates with global healthcare institutions and technology firms to integrate its AI solutions into existing medical systems. Headquartered in Seoul, South Korea, the company holds a vital role in the intersection of healthcare and technology, pushing advancements in AI applications for medical diagnostics and shaping future healthcare delivery models through cutting-edge machine learning techniques.
“Lunit Inc. trades at a P/E of -11.4 (undervalued) with modest ROE of -41.2%. 3Y revenue CAGR of 101.3% highlights clear growth momentum.”
Ask for details →